Mycothiazole, originally derived from the marine sponge Petrosaspongia mycofijiensis, has been shown to have anticarcinoma impacts in cancerous cells via inhibiting hypoxic HIF-1 signaling and causing mitochondrial dysfunction in human breast tumor T47D cells [144]. Here, HIF1A is linked to breast neoplasm.